Chronic (-) deprenyl administration increases dendritic arborization in CA3 neurons of hippocampus and AChE activity in specific regions of the primate brain

Brain Research

Volumn 796, Issue 1-2, 1998, Pages 38-44

  Lakshmana, Madepalli K ^a   Shankaranarayana Rao, B S ^a   Dhingra, Narender K ^a   Ravikumar, R ^a   Govindaiah, ^a   RaMacHandra, ^b   Meti, B L ^a   Raju, T R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

( ) Deprenyl; AChE activity; CA3 pyramidal neuron; Dendritic morphology; MAO A; MAO B; Primate brain region

Indexed keywords

ACETYLCHOLINESTERASE; SELEGILINE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CHOLINERGIC TRANSMISSION; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MONKEY; MOTOR CORTEX; NERVE CELL GROWTH; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; DENDRITES; HIPPOCAMPUS; MACACA RADIATA; MALE; MONOAMINE OXIDASE INHIBITORS; PYRAMIDAL CELLS; SELEGILINE; TISSUE DISTRIBUTION;

EID: 0032527048     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00312-6     Document Type: Article

References (52)

1. Agnoli A., Martucci N., Fabbrini G., Buckley A.E., Fioravanti M. Monoamine oxidase and dementia: treatment with an inhibitor of MAO-B activity. Dementia. 1:1990;109-114.
2. Appleyard M.E. Secreted acetylcholinesterase: non-classical aspects of a classical enzyme. Trends Neurosci. 15:1992;485-490.
3. Appleyard M.E. Acetylcholinesterase induced long-term potentiation in CA1 pyramidal cells by a mechanism dependent on metabotropic glutamate receptors. Neurosci. Lett. 190:1995;25-28.
4. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
5. Carillo M.C., Kitani K., Kanai S., Sato Y., Miyasaka K., Ivy G.O. (-) Deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice. Life Sci. 54:1994;975-981.
6. Cohen G., Spina M.B. (-) Deprenyl suppresses the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26:1981;689-690.
7. Dekosky S.T., Harbaugh R.E., Schmitt F.A., Bakay R.A.E., Chui H.C., Khopman D.S., Reeder T.M., Shétter A.G., Senter H.J., Markesbery W.R. The intraventricular Bethanicol study group, cortical biopsy tissue in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological and cognitive correlations. Ann. Neurol. 32:1992;625-632.
8. Drago F., Continella G., Spadaro F., Cavaliere S., Scapagnini F. Behavioral effects of (-) deprenyl in aged rats. Funct. Neurol. 1:1986;1165-1174.
9. Dunnett S.B., Fibiger H.C. Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia. Prog. Brain Res. 98:1993;413-420.
10. Dupree J.L., Bigbee J.W. Retardation of neuritic outgrowth and cytoskeletal changes accompany acetylcholinesterase inhibitor treatment in cultured rat dorsal root ganglion neurons. J. Neurosci. Res. 39:1994;567-575.
11. Ellman G.L., Courtney K.D., Valentino A. Jr., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;78-95.
12. Elsworth J.D., Redmond D.E. Jr., Roth R.H. Plasma. Cerebrospinal fluid 3-methoxy-4-hydroxy phenylethyleneglycol (MHPG) as indices of brain norepinephrine metabolism in primates. Brain Res. 235:1982;115-124.
13. Fishman E.B., Siek G.C., McCallum R.D., Bird E.D., Volicer L., Marquis J.K. Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann. Neurol. 19:1986;246-252.
14. Flood D.G., Coleman P.D. Hippocampal plasticity in normal aging and decreased plasticity in Alzheimer's disease. Prog. Brain Res. 83:1990;435-443.
15. Greenfield S.A. A non-cholinergic action of acetylcholinesterase (AChE) in the brain: from neuronal secretion to the generation of movement. Mol. Cell. Neurobiol. 11:1991;55-77.
16. Gundappa G., Desiraju T. Deviations in brain development of F2 generation on caloric undernutrition and scope of their prevention by rehabilitation: alterations in dendritic spine production and pruning of pyramidal neurons of lower laminae of motor cortex and visual cortex. Brain Res. 456:1988;205-223.
17. Hammond P., Brimijoin S. Acetylcholinesterase in Huntington's and Alzheimer's disease: simultaneous enzyme assay and immunoassay of multiple brain regions. J. Neurochem. 50:1988;1111-1116.
18. Inestrosa N.C., Sato C. Molecular biology of the amyloid of Alzheimer's disease: an overview. Biol. Res. 25:1992;63-72.
19. Iwasaki Y., Ikada K., Shiojima T., Kobayashi T., Tayana N., Kinoshita M. (-) Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons. J. Neurol. Sci. 125:1994;11-13.
20. Jones S.A., Holmes C., Budd T.C., Greenfield S.A. The effect of acetylcholinesterase and its inhibitors on the outgrowth and survival of rat midbrain dopaminergic neurons in organotypic slice culture. Cell Tissue Res. 279:1995;323-330.
21. Ju W.Y.H., Holland D.P., Tatton W.G. (-) Deprenyl alters the time course of death of axotomised facial motoneurons and the hypertrophy of neighbouring astrocytes in immature rats. Exp. Neurol. 126:1994;233-246.
22. Knoll J. The striatal dopamine dependency of life span in male rats, longevity with (-) deprenyl. Mech. Ageing Dev. 46:1988;237-262.
23. Lakshmana M.K., Shankaranarayana Rao B.S., Dhingra N.K., Ravikumar R., Govindaiah, Sudha S., Meti B.L., Raju T.R. Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain. Neurochem. Res. 23:1998;1033-1039.
24. Layer P.G., Kaulich L. Cranial nerve growth in birds is preceded by cholinesterase expression during neural crest cell migration and the formation of an HNK-1 scaffold. Cell Tissue Res. 265:1991;393-407.
25. Layer P.G., Weikert T., Willbold E. Chicken retinosperiods as developmental and pharmacological in vitro models: acetylcholinesterase is regulated by its own and butyrylcholinesterase activity. Cell Tissue Res. 268:1992;409-418.
26. Layer P.G., Weikert T., Alber R. Cholinesterases regulate neurite outgrowth of chick nerve cells in vitro by means of a nonenzymatic mechanism. Cell Tissue Res. 273:1993;219-226.
27. Lieberman A., Fazzini E. Experience with selegiline and levodopa in advanced Parkinson's disease. Acta Neurol. Scand. 135:1991;66-69.
28. Lipton S.A., Frosch M.P., Phillips M.D., Truck D.L., Aizenman E. Nicotinic antagonists enhance process outgrowth by rat retinal ganglion cells in culture. Science. 239:1988;1293-1296.
29. Lipton S.A., Kater S.B. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci. 12:1989;265-270.
30. Mangoni A., Grassi M.P., Frattola L. Effects of MAO-B inhibitor in the treatment of Alzheimer's disease. Exp. Neurol. 31:1991;100-107.
31. Mann J.J., Aarons S.F., Wilner P.J. A controlled study of the antidepressant efficacy and side effects of (-) deprenyl. Arch. Gen. Psychiatry. 46:1989;45-50.
32. Mendlewicz J., Youdim M.B.H. L-Deprenyl, a selective monoamine oxidase type B inhibitor in the treatment of depression, a double-blind evaluation. Br. J. Psychiatry. 142:1983;508-511.
33. Parkinson study group Effect of tocopherol and (-) deprenyl to the progression of disability in early Parkinson's disease. N. Engl. J. Med. 328:1993;176-183.
34. Paterson I.A., Juorio A.V., Berry M.D., Zhu M.Y. Inhibition of monoamine oxidase by (-) deprenyl potentiates neuronal responses to dopamine catabolism in rat striatum. J. Pharmacol. Exp. Ther. 258:1991;1019-1026.
35. Piccinin G.L., Finali G., Piccirilli M. Neuropsychological effects of L-deprenyl in Alzheimer's type dementia. Clin. Neuropharmacol. 13:1990;147-163.
36. Poewe W., Gerstenbrand F., Ransmayer G. Experience with selegiline in the treatment of Parkinson's disease. J. Neural Transm. 25:1987;131-135.
37. Ravikumar R., Lakshmana M.K., Shankaranarayana Rao B.S., Meti B.L., Bindu P.N., Raju T.R. (-) Deprenyl attenuates spinal motor neuron degeneration and associated locomotor deficits in rats subjected to spinal cord ischemia. Exp. Neurol. 149:1998;123-129.
38. Robertson R.T. A morphogenic role for transiently expressed acetylcholinesterase in developing thalamocortical systems. Neurosci. Lett. 75:1987;259-264.
39. Robertson R.T., Broide R.S., Yu J., Leslie F.L. Transiently expressed acetylcholinesterase in developing thalamocortical axons: cholinergic or non-cholinergic function? J. Neurochem. 65:1995;S127B. Suppl.
40. Robertson R.T., Yu J. Acetylcholinestrase and neural development: new tricks for an old dog. News Physiol. Sci. 8:1993;266-272.
41. Ross L.R., Parrett T., Easter S.S. Jr. Axogenesis and morphogenesis in the embryonic zebrafish brain. J. Neurosci. 12:1992;467-482.
42. Seniuk N.A., Hendersen J.T., Tatton W.G., Roder J.C. Increased CNTF gene expression in process bearing astrocytes following injury is augmented by R(-)deprenyl. J. Neurosci. Res. 37:1994;278-286.
43. Shankarnarayana Rao B.S., Desiraju T., Raju T.R. Neuronal plasticity induced by self-stimulation rewarding experience in rats - a study on alteration in dendritic branching in pyramidal neurons of hippocampus and motor cortex. Brain Res. 627:1993;216-224.
44. D.A. Sholl, The organization of the cerebral cortex, Methuen, London, 1956.
45. A. Silver, The significance of cholinesterase in the developing nervous system, in: O. Eranko (Ed.), Progress in Brain Research, Elsevier, Amsterdam, Vol. 34, 1971, pp. 346-355.
46. Small D.H. Non-cholinergic action and acetylcholinesterase: proteases regulating cell growth and development? Trends Biochem. Sci. 15:1990;213-216.
47. Small D.H. A non-classical action of acetylcholinesterase and acetylcholine in the regulation of neurite outgrowth. J. Neurochem. 65:1995;S126C. Suppl.
48. Small D.H., Reed G., Whitefield B., Nurcomber V. Cholinergic regulation of neuritic outgrowth from isolated chick sympathetic neurons in culture. J. Neurosci. 15:1995;144-151.
49. B.H. Wainer, M.M. Mesulam, Ascending cholinergic pathways in the rat brain, in: M. Steraide, D. Biesold (Eds.), Brain Cholinergic Systems, Oxford Univ. Press, New York, 1990.
50. B.J. Winer, Statistical principles in experimental design, 2nd edn., McGraw-Hill, New York, 1971.
51. Winkler J., Suhr S.T., Gage F.H., Thal L.J., Fisher L.J. Essential role of neocortical acetylcholine in spatial memory. Nature. 375:1995;484-487.
52. Zheng J.Q., Felder M., Cannor J.A., Poo Mu-ming Turning of nerve growth cones induced by neurotransmitters. Nature. 368:1994;140-144.